ZBTB41 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.911200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.730800E-01
Normal-vs-Stage2
7.713800E-01
Normal-vs-Stage3
1.044110E-02
Normal-vs-Stage4
5.747400E-01
Stage1-vs-Stage2
2.069200E-01
Stage1-vs-Stage3
2.979600E-02
Stage1-vs-Stage4
9.138800E-01
Stage2-vs-Stage3
9.166300E-02
Stage2-vs-Stage4
2.363200E-01
Stage3-vs-Stage4
5.721800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.219400E-01
Normal-vs-AfricanAmerican
4.626800E-01
Normal-vs-Asian
6.054200E-01
Caucasian-vs-AfricanAmerican
1.247820E-01
Caucasian-vs-Asian
7.643600E-01
AfricanAmerican-vs-Asian
1.402180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.354000E-01
Normal-vs-Female
7.507600E-01
Male-vs-Female
7.091800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.663400E-01
Normal-vs-Age(41-60Yrs)
8.140000E-01
Normal-vs-Age(61-80Yrs)
6.346600E-01
Normal-vs-Age(81-100Yrs)
5.110400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.595400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.698800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.452800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.309910E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.347000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.517800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.797000E-01
Normal-vs-Daily Drinker
2.179600E-01
Normal-vs-Weekly Drinker
6.647200E-01
Normal-vs-Occasional Drinker
6.995800E-01
Normal-vs-Social Drinker
9.057800E-01
Non Drinker-vs-Daily Drinker
2.344600E-01
Non Drinker-vs-Weekly Drinker
9.574200E-01
Non Drinker-vs-Occasional Drinker
3.968000E-02
Non Drinker-vs-Social Drinker
2.744600E-01
Daily Drinker-vs-Weekly Drinker
3.952400E-01
Daily Drinker-vs-Occasional Drinker
8.103900E-03
Daily Drinker-vs-Social Drinker
8.898400E-02
Weekly Drinker-vs-Occasional Drinker
1.734560E-01
Weekly Drinker-vs-Social Drinker
3.950200E-01
Occasional Drinker-vs-Social Drinker
6.946600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.837800E-02
Normal-vs-Grade 2
8.758400E-03
Normal-vs-Grade 3
3.230100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.960000E-01
Grade 1-vs-Grade 3
3.644400E-01
Grade 1-vs-Grade 4
4.837800E-02
Grade 2-vs-Grade 3
2.097200E-01
Grade 2-vs-Grade 4
8.758400E-03
Grade 3-vs-Grade 4
3.230100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.360200E-01
Normal-vs-NonDiabetic
7.065800E-01
Diabetic-vs-NonDiabetic
2.979000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.347170E-01
Normal-vs-NoPancreatitis
7.400800E-01
Pancreatitis-vs-NoPancreatitis
6.595700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.427400E-01
Normal-vs-N1
7.760000E-01
N0-vs-N1
8.371000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.415600E-01
Normal-vs-TP53-NonMutant
9.502000E-01
TP53-Mutant-vs-TP53-NonMutant
6.316000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
